Veronica Lazzarini

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels

Franca Fruzzetti, Daria Perini, Veronica Lazzarini et al. · Fertility and Sterility · 2008 · 90 citations

Obesity, Metabolic Syndrome, Adolescent Girls +10

Longitudinal evaluation of perimenopausal bone loss: Effects of different low dose oral contraceptive preparations on bone mineral density

Marco Gambacciani, Barbara Cappagli, Veronica Lazzarini et al. · Maturitas · 2005 · 60 citations

Perimenopausal Bone Loss, Contraception, Hormonal Contraceptive +14

Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome

Franca Fruzzetti, Daria Perini, Veronica Lazzarini et al. · Gynecological Endocrinology · 2009 · 48 citations

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Franca Fruzzetti, Daria Perini, Veronica Lazzarini et al. · Fertility and Sterility · 2009 · 41 citations

Mg Drospirenone, Cardiometabolic Risk, Gynecology +16

The oral contraceptive containing 30 μg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study

Franca Fruzzetti, Stefano Lello, Veronica Lazzarini et al. · Contraception · 2007 · 32 citations

Hormonal Contraceptive, Oral Contraceptive, Extracellular Water +16